Editorial Policy at MJCTT

MJCTT Journal Scope and Editorial Policies: Advancing Ethical and High-Impact Clinical Research

The Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) is committed to publishing high-quality, peer-reviewed research that advances knowledge in clinical trials, therapeutic development, and evidence-based medicine. Below is a detailed overview of our journal’s scope, peer review process, and editorial policies, aligned with best practices in scholarly publishing.

---

1. Scope of Content: Clinical Trials & Therapeutic Innovation

MJCTT welcomes a broad range of submissions that contribute to the advancement of clinical and therapeutic sciences. We accept:

• Original research articles
• Systematic reviews and meta-analyses
• Clinical trial protocols
• Case studies
• Editorials and expert opinions
• Brief communications

Topical areas of interest include:

• Interventional and observational clinical trials
• Pharmacological and non-pharmacological therapies
• Drug development and regulatory science
• Translational, personalized, and precision medicine
• Clinical trial methodology and design
• Safety, efficacy, and post-marketing surveillance
• Bioethics and research ethics in clinical studies
• Therapeutic breakthroughs in global and underserved settings

---

2. Peer Review Process: Rigorous and Fair Evaluation

All manuscripts submitted to MJCTT undergo a double-blind peer review, evaluated by at least two independent experts in the field.

The review process focuses on:

• Scientific validity and originality
• Methodological rigor
• Ethical compliance
• Relevance to clinical trials and therapeutic research

In cases of conflicting reviewer recommendations, a third reviewer or a senior editor is consulted. Authors are expected to revise manuscripts in response to reviewer feedback prior to final editorial decisions.

---

3. Authorship & Contributor Roles

MJCTT follows the ICMJE authorship criteria, requiring that all authors:

• Contribute substantially to the study design, data collection, or analysis
• Draft or critically revise the manuscript
• Approve the final version
• Accept accountability for the accuracy and integrity of the work

All contributions must be transparently acknowledged, with a clear statement of each author’s role.

---

4. Ethical Standards: Commitment to COPE Guidelines

MJCTT adheres to the ethical standards set by the Committee on Publication Ethics (COPE).

Authors must ensure:

• Ethics committee approval for all human and animal studies
• Documented informed consent where applicable
• Disclosure of financial or non-financial conflicts of interest
• No plagiarism, data fabrication, or duplicate publication

Violations may result in immediate rejection or post-publication retraction.

---

5. Open Access Policy: Free and Unrestricted Access

MJCTT is a fully open-access journal. All articles are made freely available upon publication under the Creative Commons Attribution License (CC BY 4.0), allowing unrestricted use, sharing, and adaptation with proper citation.

---

6. Data Transparency & Availability

We strongly encourage authors to provide data availability statements and deposit supporting datasets in public repositories whenever possible.

Exceptions may apply for ethical, legal, or proprietary restrictions.

---

7. Corrections, Retractions & Expressions of Concern

To ensure the integrity of the scholarly record, MJCTT will:

• Publish corrections for honest errors
• Issue retractions for proven misconduct or serious flaws
• Post expressions of concern when investigations are ongoing

All notices are transparently linked to the original article.

---

8. Editorial Independence

All editorial decisions are made free from commercial influence or institutional bias. Editors and reviewers are selected based on subject-matter expertise and commitment to scientific integrity.

MJCTT does not accept advertisements or sponsorships that could compromise editorial objectivity.

---

9. Appeals & Complaints Procedure

Authors may appeal editorial decisions by submitting a detailed justification. Appeals are reviewed by a senior editor or independent appeals committee.

Ethical complaints are investigated thoroughly in accordance with COPE procedures. Please direct concerns to the Editor-in-Chief.

---

10. Indexing and Archiving Strategy

MJCTT is actively pursuing indexing in reputable scholarly databases such as:

• DOAJ (Directory of Open Access Journals)
• Scopus
• PubMed Central

We are committed to ensuring long-term preservation, discoverability, and citation of all published content.

---

📩 Contact Us

For questions related to editorial policies or manuscript submissions, please contact:
📧 Email: editors_mjctt@mogitojournals.org
🌐 Website: www.mogitojournals.org